Search for: "MYLAN PHARMACEUTICALS" Results 1 - 20 of 739
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Dec 2008, 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals Corp., Novartis Corp., and Novartis International AG over a generic version of Novartis' Femara ® tablets.According to the press release, Femara ® tablets, which are used in the treatment of breast cancer, had U.S. sales of about $470 million for the 12 months ending September 30, 2008.… [read post]
9 Jan 2020, 8:25 pm by Brianna Smith
Mylan Pharmaceuticals Inc. is recalling certain batches of its Nizatidine Capsules, USP, over concerns they may contain a carcinogen. [read post]
6 Sep 2016, 3:36 pm by Cynthia Marcotte Stamer
The New York Attorney General is investigating whether leading EpiPen Manufacturer, Mylan Pharmaceuticals, violated New York antitrust laws by inserting anticompetitive terms into its EpiPen sales contracts with numerous local school systems. [read post]
31 Jan 2017, 8:55 pm by Patent Docs
The question arose in ANDA litigation between patentee and NDA holder Cumberland Pharmaceuticals and Mylan. [read post]
7 Dec 2023, 9:59 pm by Patent Docs
Mylan Pharmaceuticals Inc., with the Court vacating and remanding the District Court's claim construction for failure to consider extrinsic evidence. [read post]
5 Apr 2020, 9:57 pm by Patent Docs
Mylan Pharmaceuticals Inc., the Federal Circuit reversed a decision by the U.S. [read post]
15 Aug 2022, 3:10 am by Moll Law Group
Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units/mL, 3 mL. [read post]
4 Jun 2020, 12:51 pm
Jane Lambert Patents Court (Mr Justice Msrcus Smith) Neurim Pharmaceuticals (1991) Ltd and another v Generics UK Ltd (t/a Mylan) and another [2020] EWHC 1362 (Pat) (3 June 2020) This was an application by Neurim Pharmaceuticals (1991) Ltd. [read post]
5 Oct 2022, 8:12 pm by Patent Docs
Patent No. 7,326,708 were either anticipated or rendered obvious by the asserted prior art, in Mylan Pharmaceuticals Inc. v. [read post]
9 Dec 2021, 7:15 am by Logan Murr
The decision relates to AstraZeneca AB’s and AstraZeneca Pharmaceuticals LP’s (collectively “AstraZeneca”) lawsuit against Mylan and Kindeva Drug Delivery LP (collectively “Mylan”) for infringing all claims of U.S. [read post]
8 Dec 2021, 8:52 am by Lawrence B. Ebert
The outcome AstraZeneca AB and AstraZeneca Pharmaceuticals LP (collectively, “AstraZeneca”) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
10 Jun 2009, 9:02 pm
Seeking approval to market a generic version of levofloxacin, Defendants-Appellants Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. filed an Abbreviated New Drug Application (ANDA) with the FDA. [read post]
22 Jul 2018, 8:32 pm by Patent Docs
Mylan Pharmaceuticals, affirming the decision by the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
20 Jan 2022, 4:41 pm by Brianna Smith
Mylan Pharmaceuticals is recalling certain Semglee prefilled insulin injection pens because they may not be properly labeled. [read post]
30 Mar 2022, 7:34 am
Author The Judicial Office, UK Licence CC BYSA 4.0 Source Wikimedia CommonsJane LambertPatents Court (Mr Justice Mellor) Neurim Pharmaceuticals (1991) Ltd and another v Generics UK Ltd (t/a Mylan) and another [2021] EWHC 2198 (Pat) (2 Aug 2021)This case shows how quickly the English courts can move to resolve disputes when there is a need for them do so. [read post]